Clinical And Patient-Reported Outcomes Of An Enhanced Monofocal Intraocular Lens With Modified Optical Profile: 18 Months Follow-Up
Published 2024 - 42nd Congress of the ESCRS
Reference: PO318 | Type: Free paper | DOI: 10.82333/6phz-2b65
Authors: Alireza Mirshahi* 1 , Annika Licht 1 , Katharina Ponto 2 , Catharina Latz 1
1Dardenne Eye Hospital,Bonn,Germany, 2Dardenne Eye Hospital,Bonn,Germany;Ophthalmology,University Medical Center,Mainz,Germany
Purpose
To assess the clinical and patient-reported outcomes of an enhanced monofocal intraocular lens (IOL) with a modified optical profile (monofocal plus).
Setting
Dardenne Eye Hospital, Bonn, Germany
Methods
This study enrolled 41 subjects (aged 48-84 years) undergoing bilateral cataract surgery with implantation of the Eyhance IOL (Johnson & Johnson Vision). Monocular and binocular visual outcomes were evaluated at 18 months post-surgery, along with refractive results. Additionally, the perception of photic phenomena, patient satisfaction, and difficulty in performing vision-related activities were assessed using a validated questionnaire (PRSIQv2).
Results
The mean postoperative uncorrected distance visual acuity (UDVA) was 0.11±0.10 and 0.10±0.09 logMAR in the right and left eyes, respectively. The mean postoperative spherical equivalent was 0.05±0.47 and 0.19±0.53 D, respectively. Uncorrected intermediate visual acuity (UIVA) had mean values of 0.27±0.15 and 0.24±0.14 logMAR, respectively. Halos and glare were reported by 4 patients (9.8%).
Conclusions
At 18 months post-surgery, the evaluated enhanced monofocal IOL (monofocal plus) provided excellent distance visual rehabilitation and satisfactory intermediate vision. The incidence of photic phenomena was comparable to that observed with conventional monofocal IOLs.